• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device stimulator, electrical, implanted, for parkinsonian symptoms
Definition Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic Activa Parkinson's Control Therapy is indicated for adjunctive therapy in reducing some of the symptoms of advanced, levodopa-responsive Parkinsons disease that are not adequately controlled with medication.
Product CodeNHL
Device Class 3

Premarket Approvals (PMA)
2021 2022 2023 2024 2025 2026
8 6 12 14 10 4

MDR Year MDR Reports MDR Events
2021 205 208
2022 214 220
2023 411 415
2024 396 400
2025 197 197
2026 63 63

Device Problems MDRs with this Device Problem Events in those MDRs
Adverse Event Without Identified Device or Use Problem 835 848
Unexpected Therapeutic Results 288 290
High impedance 121 125
Migration 107 107
Charging Problem 69 69
Battery Problem 62 62
Wireless Communication Problem 53 54
Inappropriate/Inadequate Shock/Stimulation 40 40
Intermittent Energy Output 34 34
Use of Device Problem 28 29
Premature Discharge of Battery 24 25
Fracture 23 23
Inappropriate or Unexpected Reset 21 21
Off-Label Use 14 14
Defective Device 13 14
Overheating of Device 12 12
Low impedance 10 10
Delayed Charge Time 9 9
Appropriate Term/Code Not Available 8 8
Failure to Disconnect 7 7
Nonstandard Device 7 7
Positioning Problem 6 6
Device Displays Incorrect Message 5 5
Power Problem 5 6
Insufficient Information 4 4
Difficult to Remove 3 3
Mechanical Problem 3 3
Material Twisted/Bent 2 2
Difficult to Insert 2 2
Defibrillation/Stimulation Problem 2 2
Therapeutic or Diagnostic Output Failure 2 2
Unintended Movement 2 2
Patient-Device Incompatibility 2 2
Energy Output Problem 2 2
Communication or Transmission Problem 2 2
Inadequate or Insufficient Training 2 2
Migration or Expulsion of Device 2 2
Impedance Problem 1 1
Patient Device Interaction Problem 1 1
Structural Problem 1 1
Environmental Compatibility Problem 1 1
Packaging Problem 1 1
No Apparent Adverse Event 1 1
Defective Alarm 1 1
Computer Software Problem 1 1
Device Dislodged or Dislocated 1 1
Malposition of Device 1 1
Pocket Stimulation 1 1
Difficult to Open or Close 1 1
Device Contaminated During Manufacture or Shipping 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 341 345
Bacterial Infection 173 174
Swelling/ Edema 145 146
Unspecified Infection 140 141
Shaking/Tremors 131 132
Insufficient Information 117 117
Movement Disorder 103 105
Pain 77 78
Erosion 76 76
Undesired Nerve Stimulation 69 69
Inadequate Pain Relief 64 65
Discomfort 57 57
Inflammation 57 57
Wound Dehiscence 55 56
Intracranial Hemorrhage 51 52
Impaired Healing 51 52
Convulsion/Seizure 51 53
Speech Disorder 44 46
Fluid Discharge 44 44
Hemorrhage/Bleeding 38 39
Confusion/ Disorientation 36 37
Purulent Discharge 35 35
Hematoma 35 36
Fall 33 33
Erythema 32 32
Muscle Weakness 30 30
Cognitive Changes 29 29
Burning Sensation 28 28
Dyskinesia 26 28
Unspecified Musculoskeletal problem 18 19
Paralysis 17 17
Skin Inflammation/ Irritation 16 17
Headache 16 16
Implant Pain 15 16
Paresthesia 14 15
Pocket Erosion 13 13
Urinary Incontinence 12 12
Fever 12 12
Stroke/CVA 11 12
Dysphasia 11 12
Dizziness 10 10
Abscess 10 10
Hypersensitivity/Allergic reaction 10 11
Scar Tissue 9 9
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 9 9
Failure of Implant 8 8
Emotional Changes 8 8
Post Operative Wound Infection 8 8
Balance Problems 7 7
Fatigue 7 7

Recalls
Manufacturer Recall Class Date Posted
1 Boston Scientific Neuromodulation Corporation II Sep-12-2025
2 Boston Scientific Neuromodulation Corporation II Aug-19-2025
3 Boston Scientific Neuromodulation Corporation II May-24-2024
-
-